KalVista Pharmaceuticals
KALV
KALV
69 hedge funds and large institutions have $122M invested in KalVista Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-4
Holders Change %
-5.48%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
10
Increased
26
Reduced
21
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$11.3M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$5.62M |
| 3 |
O
OrbiMed
New York
|
+$1.99M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$1.97M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.72M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$312K | -17,500 | Closed |
|
|
QSS
77
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
| – | -$227K | -12,738 | Closed |
|
78
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$28K | -1,579 | Closed |
|
|
PCM
79
Prelude Capital Management
New York
| – | -$3K | -184 | Closed |
|
|
MAM
80
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -137 | Closed |
|